about
Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data.[Diagnosis of inherited thrombocytopenia].Spectrum of the mutations in Bernard-Soulier syndrome.Expanded repertoire of RASGRP2 variants responsible for platelet dysfunction and severe bleeding.Modulation of T Cell Activation in Obesity.FPR2: A Novel Promising Target for the Treatment of Influenza.Gray platelet syndrome can mimic autoimmune lymphoproliferative syndrome.Impact of obesity and the metabolic syndrome on response to clopidogrel or prasugrel and bleeding risk in patients treated after coronary stenting.Protease-activated receptor 1 inhibition protects mice against thrombin-dependent respiratory syncytial virus and human metapneumovirus infections.A new heterozygous mutation in GP1BA gene responsible for macrothrombocytopenia.Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort.Multilevel systems biology modeling characterized the atheroprotective efficiencies of modified dairy fats in a hamster model.CD28 deletion improves obesity-induced liver steatosis but increases adiposity in mice.α1 -antitrypsin Pittsburgh and plasmin-mediated proteolysis.Clinical and Laboratory Findings in Patients with δ-Storage Pool Disease: A Case Series.Minor allele of the factor V K858R variant protects from venous thrombosis only in non-carriers of factor V Leiden mutationLipodystrophy-like features after total body irradiation among survivors of childhood acute leukemiaThromboxane-prostaglandin receptor antagonist, terutroban, prevents neurovascular events after subarachnoid haemorrhage: a nanoSPECT study in ratsStrengths and Weaknesses of Light Transmission Aggregometry in Diagnosing Hereditary Platelet Function DisordersPlatelet CD40 ligand and bleeding during P2Y12 inhibitor treatment in acute coronary syndromeValidation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSCIncreased levels of the megakaryocyte and platelet expressed cysteine proteases stefin A and cystatin A prevent thrombosisA Novel Rapid Method of Red Blood Cell and Platelet Permeabilization and Staining for Flow Cytometry AnalysisPlatelet reactivity inhibition following ticagrelor loading dose in patients undergoing percutaneous coronary intervention for acute coronary syndromeHigh prevalence of mutations in perilipin 1 in patients with precocious acute coronary syndromeAugmenting pharmacotherapy with neuromodulation techniques for the treatment of bipolar disorder: a focus on the effects of mood stabilizers on cortical excitabilityAn integrated approach to inherited platelet disorders: results from a research collaborative, the Sydney Platelet GroupBinding of Coagulation Factor XIII Zymogen to Activated Platelet Subpopulations: Roles of Integrin αIIbβ3 and FibrinogenNovel ACTN1 variants in cases of thrombocytopenia
P50
Q31028203-059D381C-4454-4E0D-9B7B-4FBEB41797CBQ33427959-E2AB2236-FF27-4E2F-B145-5D219169BD0CQ38220681-2E5DEEFE-B87E-43E8-BCE6-BF0356E71F4FQ38715111-86CC6E71-369D-4438-B744-9717BB51C762Q38844262-9AACA3E9-C225-43A3-844E-4689CD76746AQ41450597-4037D4B5-F60B-4401-BF7A-8DFDDC0663D9Q43124182-F2DD4F2D-A0EB-4966-9C07-C48F69EF0E83Q44904815-ED56409B-AC29-41F5-B878-F17C35965481Q45325250-940E5E77-3C4C-47C6-81F9-07521FD89304Q48106594-849BADBC-54FE-4FBB-97FF-FF16D45B75E5Q49155547-82028D58-B2F6-4F08-B3F0-2FBBED2CC59EQ50899570-B9D2880A-846F-4981-8F64-DEFD520C8B49Q51306467-2947C186-4F04-4C5C-B943-6EFE6498E40DQ51610329-BC38553A-4608-4466-8CA8-54DF281E1F43Q53598749-C982553B-66CA-4370-B15D-CBB295246005Q64059436-DBCB2D4B-8986-45DB-B7B5-AA09343AE0A4Q64120379-DE739728-F1A6-4562-AECF-6A3A57910905Q64236955-C10B943E-843A-4A67-A9A2-BAFB00EF10C5Q90362013-F3BCCD33-96E0-4F56-A3F0-9B366C873CE9Q90784774-64F3DA70-9BAC-4C6D-8790-A8DBA4D5CCA9Q91371002-DF7081F0-E796-46EF-B66F-BF9C872C6017Q91594521-C2D69ED4-F161-41A3-8AE1-B4851B6EC492Q91845167-B014A5A7-B803-4D6F-B586-BD8942C143A8Q92218977-B1535FA7-69EE-45B2-A30C-B266B54EA357Q92253606-47FF79FC-ABD8-45AB-88DE-0C492C37988EQ92439791-EA206C6C-C0A4-45BD-A2BE-7A46D4B23EB2Q92606316-96CF8FFF-6699-4430-837C-AB9D5BBC2EE9Q92751672-F9AEFF1E-E640-4B70-9EF6-D1B4E4954E3EQ93012480-8DA810FF-D78E-4B77-B821-B369C06D940C
P50
description
researcher (ORCID 0000-0003-3927-5792)
@en
name
Marie-Christine Alessi
@br
Marie-Christine Alessi
@co
Marie-Christine Alessi
@da
Marie-Christine Alessi
@de
Marie-Christine Alessi
@en
Marie-Christine Alessi
@es
Marie-Christine Alessi
@fr
Marie-Christine Alessi
@id
Marie-Christine Alessi
@it
Marie-Christine Alessi
@nds
type
label
Marie-Christine Alessi
@br
Marie-Christine Alessi
@co
Marie-Christine Alessi
@da
Marie-Christine Alessi
@de
Marie-Christine Alessi
@en
Marie-Christine Alessi
@es
Marie-Christine Alessi
@fr
Marie-Christine Alessi
@id
Marie-Christine Alessi
@it
Marie-Christine Alessi
@nds
prefLabel
Marie-Christine Alessi
@br
Marie-Christine Alessi
@co
Marie-Christine Alessi
@da
Marie-Christine Alessi
@de
Marie-Christine Alessi
@en
Marie-Christine Alessi
@es
Marie-Christine Alessi
@fr
Marie-Christine Alessi
@id
Marie-Christine Alessi
@it
Marie-Christine Alessi
@nds
P106
P21
P31
P496
0000-0003-3927-5792